Specifically designed for in vitro diagnostic use, the Atellica® CH Tacrolimus (TACR) assay provides precise quantitative analysis of tacrolimus and its metabolites in human whole blood.
Utilized as a crucial tool in the management of tacrolimus medication therapy for liver and kidney transplant recipients, ensuring optimal dosage and patient safety.
Compatible exclusively with the Atellica® CH Analyzer, offering up to 400 tests for efficient and reliable monitoring.
Streamlines laboratory workflows with its easy-to-use format, enhancing the efficiency of transplant monitoring protocols.
Manufactured by Siemens, a trusted name in medical supplies and equipment, ensuring high-quality and reliable results.
